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ABSTRACT 
Pterygium is a triangle-shaped fibrovascular hyperplasia of the bulbar conjunctiva on the cornea. The purpose of this 
study was to analyze Proteoglycans (PGs) by Immunohistochemistry (IHC) in pterygium tissues and to compare the 
results with normal conjunctiva. Twenty-four patients (14 males) undergoing primary pterygium excision and 17 healthy 
individuals (10 males), undergoing extracapsular cataract surgery, were included. Pterygium tissues and normal 
conjunctiva tissues were surgically removed. The tissue sections were fixed in 2% paraformaldehyde and incubated with 
monoclonal antibodies against PGs anti-mouse IgG. Immunohistochemical study showed stronger expression of keratan 
sulfate in the stroma of the pterygium compared to normal conjunctiva. An increased expression of heparan sulfate was 
observed in the epithelial layer and around the pterygium vessels. On the other hand, dermatan sulfate showed an 
increased expression and localization not only in the sub-epithelial area of the pterygium and normal conjunctiva, yet 
throughout the stroma of the pterygium. The differences in the expression and localization of the studied extracellular 
matrix proteoglycans in the pterygium tissue compared to normal conjunctiva may explain the tissue hyperplasia, 
structure, and the functional properties in pterygium. 
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INTRODUCTION
Pterygium is a triangle-shaped fibrovascular hyperplasia 
of the bulbar conjunctiva on the cornea. It is one of the 
most common external eye diseases, especially in 
tropical countries and in people, who spend a significant 
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amount of time outdoors [1]. Although the pathogenetic 
mechanism of pterygium is unclear, there are several 
hypotheses. Prolonged exposure to solar ultraviolet light 
is believed to be the main predisposing factor in the 
development of pterygium and the fact that it is usually 
detected nasally has been associated with light focused 
on this area [1, 2]. Several authors suggest that 
ultraviolet-induced alteration of limbal stem cells is an 
important factor in the invasive nature of pterygium. It is 
assumed that ultraviolet light promotes the 
transformation and overexpression of stem cells in the 
limbus [1-3]. It is suggested that mast cells are involved 
in the pathogenesis and progression of pterygium [4] 
while an immunopathogenetic mechanism, possibly type 
I and III hypersensitivity [5], and the overexpression of 
the Extracellular Matrix (ECM) molecular network have 
also been implicated [6]. Proteoglycans (PGs) comprise 
one of the most important constituents of the ECM with 
important regulatory roles in several cellular events and 
pathophysiological processes [7]. They contain one or 
more Glycosaminoglycan (GAG) chains that are 
covalently attached to a protein core and modify the 
functions of proteoglycans [8]. Glycosaminoglycans are 
linear heteropolysaccharides composed of repeated 
disaccharide units [7].  
Although it is known that the tissue of pterygium 
contains PGs, a thorough analysis of the important 
connective tissue components has not been conducted 
so far. The purpose of the current study was to evaluate 
the expression and tissue localization in three different 
GAGs, i.e. keratan sulfate, heparan sulfate, and dermatan 
sulfate, in the pterygium and normal conjunctiva. 
METHODS 
The study was conducted according to the tenets of the 
Declaration of Helsinki and received approval by the 
Institutional Review Board of the University Hospital of 
Patras. Exclusion criteria were any ophthalmic or 
systemic disease or use of topical or systemic 
medications. Informed consent was obtained from all 
eligible participants that participated in the study.  
Pterygium tissues were surgically removed, while normal 
conjunctiva tissues were obtained from the perilimbal 
conjunctiva at the 12 o’clock position during 
extracapsular cataract extraction surgery. This area was 
chosen because it is protected from ultraviolet light by 
the upper lid. Specimens from pterygium and normal 
conjunctiva were obtained, formalin fixed, and paraffin 
embedded serial sections were immunostained using 
specific monoclonal antibodies against keratan sulfate, 
heparan sulfate, and dermatan sulfate. Tissue sections 
were incubated with mouse primary monoclonal 
antibodies at 4oC overnight. They were then extensively 
washed in 50 millimole tris-buffered saline, pH 7.6, 
before the addition of a biotinylated goat anti-mouse 
secondary antibody. Immunoreactivity was performed by 
adding 3, 3’-diaminobenzidine tetrahydrochloride 
(Sigma, Sydney, Australia). Following immunostaining, 
the tissue sections were examined meticulously, using 
light microscopy. A negative control of the technique was 
accomplished without the primary antibody. The primary 
antibodies used to identify the distribution of pterygium 
and normal conjunctival PGs/GAGs were monoclonal 
antibodies against heparan sulfate (clone 10E4) diluted 
1:20, -keratan sulfate (clone 5D4) diluted 1:200, and 
dermatan sulfate proteoglycan decorin (clone 6B6) 
diluted 1:1000 (Seikagaku Corporation, Tokyo, Japan). 
Extracted data has been analysed subsequently. 
RESULTS 
Twenty-four patients (14 males and 10 females, age of 
71.4 ± 6.2 years (mean ± Standard Deviation)) 
undergoing primary pterygium excision and 17 healthy 
individuals (10 males and 7 females, age 74.5 ± 8.2 of 
years (mean ± Standard Deviation)) undergoing 
extracapsular cataract surgery were included in the 
study. There was an increase in the expression of keratan 
sulfate, heparan sulfate, and dermatan sulfate in 
pterygium tissue compared to normal conjunctiva. More 
specifically, the immunohistochemical study provided 
evidence of increased expression of keratan sulfate in the 
stroma of pterygium tissue in 75% of the specimens 
compared to the normal conjunctiva (Fig 1A, 1B). An 
overexpression of heparan sulfate was observed in the 
epithelial layer and around the capillaries of pterygium in 
all samples studied (Fig 1C, 1D). Finally, 
immunohistochemical analysis demonstrated an 
increased expression of dermatan sulfate in the sub-
epithelial area in the pterygium tissue and in normal 
conjunctiva tissue yet also throughout the stroma of the 
pterygium in 83.3% of the specimens (Fig 1E and 1F). The 
current findings were not attributed to differences in the 
age of patients with pterygium and normal conjunctiva as 
there was no statistical significant difference between 
the mean ages of the two groups.  
DISCUSSION 
One of the major components of the ECM are PGs that 
upon interactions with several growth factors and other 
mediators, play pivotal biological roles and determine 
many cellular functions, such as the cellular adhesion, 
proliferation, migration, and cell differentiation and 
apoptosis [7]. Differences between pterygium tissue and 
normal conjunctiva in GAGs composition has been 
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previously identified using biochemical methods [9]. 
However, the expression and localization of PGs/GAGs in 
these tissues has never been studied previously. In the 
present study, using specific antibodies against certain 
GAG chains of PGs, the researchers identified that there 
were higher depositions of keratan sulfate to the tissue 
stroma compared to normal conjunctiva. Also, an 
increased expression of heparan sulfate was observed in 
the epithelial layer, as well as around the pterygium 
vessels. On the other hand, dermatan sulfate showed an 
increased expression and localization in the sub-
epithelial layer cells of both pterygium tissue and normal 
conjunctiva. Dermatan sulfate, however, was also 
expressed in the stroma of the pterygium. All these 
changes were observed in a great proportion of the 
pterygium samples studied. 
 
 
Figure 1: Immunolocalization and Distribution of Proteoglycans in Pterygium and Normal Conjunctiva Sections. Immunoreactivity against each 
Proteoglycan is denoted by arrowheads. A, B: Increased expression of keratan  sulfate (arrows) in the stroma of pterygium tissue (A) compared to the 
normal conjunctiva (B) (×200). C, D: Overexpression of heparan sulfate (arrows) in the epithelial layer and around the capillaries of pterygium (C) 
compared to the normal conjunctiva (D) (×400). E, F: Overexpression of dermatan sulfate in the sub-epithelial area (arrows) of the pterygium (E) and of 
normal conjunctiva (F), but also in the stroma of the pterygium (×200). 
The extracellular matrix seems to play a significant role in 
the pathogenesis and progression of pterygium. It has 
been revealed that there is no difference in the cellular 
proliferation pattern between pterygium and 
conjunctival tissues, proposing that the overexpression of 
ECM predominates over the cellular proliferation in the 
pterygium pathogenesis [10]. Furthermore, Kaneto 
observed the presence of PGs in the tissue of pterygium 
[11]. Akamatsu et al. reported that chondroitin sulfate 
was distributed predominantly in the apical region of 
pterygium, where elastoid fibers were also present and 
suggested that degeneration of the connective tissues 
was responsible for connective tissue overgrowth [12]. A 
recent experimental study on rabbits showed that 
subconjunctival injection of exogenous ECM alone or in 
conjunction with a fibroblast cell line resulted in tissue 
growth with characteristics of human pterygium, a fact 
that highlights the role of ECM in pterygium 
pathogenesis [13]. It is important to note, the exogenous 
ECM that was injected sub-conjunctivally in the 
experiment contained the heparin sulfate proteoglycan. 
Histopathological evaluation of pterygium demonstrates 
a variety of findings, such as squamous metaplasia of 
epithelial cells and goblet cell hyperplasia and 
fibrovascular connective tissue overgrowth with elastotic 
degenerative alterations of the connective tissue, while 
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prominent neovascularization and inflammatory cell 
infiltration was also observed [14, 15]. Significant 
changes both in the epithelium and in the underlying 
connective tissue and diffuse immune cell infiltrate has 
been shown by Golu et al. [16].  
The current study had certain limitations. A larger 
number of specimens studied could give strength to the 
study. Although localization of the specific PGs is clearly 
demonstrated, calculation of color intensity of IHC 
stained specimens in the two groups could allow analysis 
of differences between the two groups in expression of 
the PGs/GAGs statistically and report its significance with 
more confidence. 
CONCLUSION 
The current study clearly demonstrated differences in 
expression and localization of PGs/GAGs in pterygium 
and normal conjunctiva. Given the significant role of 
extracellular matrix in the pathogenesis and progression 
of various diseases it is therefore plausible to suggest 
that the overexpression and the different localization of 
the matrix PGs in the pterygium tissue, compared to 
normal conjunctiva, could contribute to tissue 
overgrowth, structural organization and junction of the 
pterygium tissue. Further studies are required in order to 
elucidate in detail whether certain PG populations are 
responsible for the pathogenicity of this disorder by 
evaluating the expression of mRNAs coding for the matrix 
and cell surface PG populations. 
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